Revance – pharmaceutical daily

June 4, 2020 Off

Revance to Participate in the 40th Annual William Blair Growth Stock Conference

NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation…

June 2, 2020 Off

Revance to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast

By BusinessWire

NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation…

June 1, 2020 Off

Revance and Mylan to Advance Development Program for Biosimilar to BOTOX®

By BusinessWire

Mylan is potentially getting access to 14 indications after approval, as first neurotoxin formulation to be developed as a potential biosimilar product to BOTOX.